These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


544 related items for PubMed ID: 33471027

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS.
    JAMA; 2007 Aug 15; 298(7):776-85. PubMed ID: 17699011
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations.
    Deng K, Pan XF, Voehler MW, Cai Q, Cai H, Shu XO, Gupta DK, Lipworth L, Zheng W, Yu D.
    J Am Heart Assoc; 2024 May 21; 13(10):e034364. PubMed ID: 38726919
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV.
    PLoS Med; 2020 Mar 21; 17(3):e1003062. PubMed ID: 32203549
    [Abstract] [Full Text] [Related]

  • 7. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).
    Mackey RH, Greenland P, Goff DC, Lloyd-Jones D, Sibley CT, Mora S.
    J Am Coll Cardiol; 2012 Aug 07; 60(6):508-16. PubMed ID: 22796256
    [Abstract] [Full Text] [Related]

  • 8. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
    Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J, Walldius G, Hellenius ML, Hamsten A.
    Eur Heart J; 2009 Mar 07; 30(6):710-7. PubMed ID: 18676970
    [Abstract] [Full Text] [Related]

  • 9. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C, Tafflet M, Barberger-Gateau P, Bertrand M, Dupuy AM, Ducimetière P, Empana JP.
    Atherosclerosis; 2011 Feb 07; 214(2):426-31. PubMed ID: 21129746
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A, Hergenç G, Sansoy V, Fobker M, Ceyhan K, Toprak S, Assmann G.
    Atherosclerosis; 2003 May 07; 168(1):81-9. PubMed ID: 12732390
    [Abstract] [Full Text] [Related]

  • 11. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease.
    Tian X, Chen S, Zuo Y, Zhang Y, Zhang X, Xu Q, Luo Y, Wu S, Wang A.
    BMC Med; 2022 Nov 10; 20(1):383. PubMed ID: 36352412
    [Abstract] [Full Text] [Related]

  • 12. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J.
    Circulation; 2004 Nov 02; 110(18):2824-30. PubMed ID: 15492318
    [Abstract] [Full Text] [Related]

  • 13. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
    Tehrani DM, Gardin JM, Yanez D, Hirsch CH, Lloyd-Jones DM, Stein PK, Wong ND.
    Atherosclerosis; 2013 Dec 02; 231(2):246-51. PubMed ID: 24267235
    [Abstract] [Full Text] [Related]

  • 14. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years.
    Simons LA, Simons J, Friedlander Y, McCallum J.
    Atherosclerosis; 2001 Nov 02; 159(1):201-8. PubMed ID: 11689222
    [Abstract] [Full Text] [Related]

  • 15. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA, Kastelein JJP, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, Laufs U, Oliver-Williams C, Wood AM, Butterworth AS, Di Angelantonio E, Danesh J, Nicholls SJ, Bhatt DL, Sabatine MS, Catapano AL.
    JAMA; 2019 Jan 29; 321(4):364-373. PubMed ID: 30694319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.